Parexel rejigs its randomization tech with an eye on speed

CRO giant Parexel ($PRXL) has updated its technology for patient randomization and clinical supply management, touting the latest version as a valuable tool for speeding up the process of designing studies. The platform, called ClinPhone RTSM, is designed to simplify study startup. And, integrating new technologies from recent acquisition ClinIntel, Parexel believes the new, fourth-generation software can further save sponsors time and money. More